Life Technologies to Present at JP Morgan 2013 Healthcare Conference

     Life Technologies to Present at JP Morgan 2013 Healthcare Conference

PR Newswire

CARLSBAD, Calif., Dec. 18, 2012

CARLSBAD, Calif., Dec. 18, 2012 /PRNewswire/ -- Life Technologies Corporation
(NASDAQ: LIFE) today announced it will present at JP Morgan 2013 Healthcare
Conference on Tuesday, Jan. 8 at 1:30 p.m. PT. Gregory T. Lucier, Life
Technologies' Chairman and Chief Executive Officer, will present on behalf of
the company. The company will webcast the presentation, which will be
available for three weeks following the conference, on the Life Technologies'
investor relations website at


About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company
with customers in more than 160 countries using its innovative solutions to
solve some of today's most difficult scientific challenges. Quality and
innovation are accessible to every lab with its reliable and easy-to-use
solutions spanning the biological spectrum, with more than 50,000 products for
agricultural biotechnology, translational research, molecular medicine and
diagnostics, stem cell-based therapies, forensics, food safety and animal
health. Its systems, reagents and consumables represent some of the most cited
brands in scientific research including: Ion Torrent™, Applied
Biosystems®,Invitrogen™, Gibco®, Ambion®, Molecular Probes®, Novex®, and
TaqMan®. Life Technologies employs approximately 10,400 people and upholds its
ongoing commitment to innovation with more than 4,000 patents and exclusive
licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website:

Investor and Financial Contact:

Carol Cox
Investor Relations
(760) 603-7208

SOURCE Life Technologies Corporation

Press spacebar to pause and continue. Press esc to stop.